Medical Mycology
What is a fungus? ★★★
Eukaryotic organisms — each fungal cell has at least one nucleus enclosed by a nuclear membrane, endoplasmic reticulum, mitochondria and a secretory apparatus. They do NOT contain chlorophyll. They are eukaryotic, SPORE-BEARING, NON-PHOTOSYNTHETIC microbes that exist widely in nature.
⭐ The relationship between fungi and humans
| Beneficial | Harmful |
|---|---|
| Biodegradation and recycling of organic matter | About 400 species cause human disease — as opportunistic pathogens and pathogens |
| Source of food | MYCOSES — infections caused by fungi: superficial, cutaneous, subcutaneous, systemic or allergic disease |
| Seasoning and flavouring | Fungal toxins → poisoning |
| Antibiotics — penicillin is extracted from Penicillium | Cancer |
- Define fungi. → Eukaryotic, spore-bearing, non-photosynthetic microbes; each cell has at least one nucleus with a nuclear membrane, ER, mitochondria and secretory apparatus, and no chlorophyll
- Give four benefits of fungi to humans. → Biodegradation and recycling of organic matter, food, seasoning and flavouring, antibiotics (penicillin from Penicillium)
- Give four harms. → About 400 species cause human disease; mycoses (superficial, cutaneous, subcutaneous, systemic, allergic); fungal toxins causing poisoning; and cancer
- Define a mycosis. → An infection caused by fungi
Structure of a fungal cell ★★★
| Organism | Size |
|---|---|
| Viruses | 0.08 µm |
| Cocci | 0.8 µm |
| Bacilli | 4–6 µm |
| Spirochaetes | 8–10 µm |
| Fungi | 10–15 µm — the largest |
| Component | Content |
|---|---|
| Cell wall | Multilayered and rigid: CHITIN, proteins, polysaccharides and lipids. NO peptidoglycan |
| Cell membrane | ERGOSTEROL instead of cholesterol — the target of some antifungal antibiotics, e.g. the azole derivatives: ketoconazole, fluconazole, itraconazole |
| Cytoplasm and organelles | Ribosome 80S · endoplasmic reticulum · mitochondria · Golgi body |
| Nucleus | One or more, with a nuclear membrane and nuclear pores |
| Capsule | e.g. Cryptococcus neoformans — thick and polysaccharide; a VIRULENCE FACTOR |
Fungi are eukaryotes, like us. That is the whole therapeutic problem: almost everything a fungal cell does, our cells do too, so there is very little to attack selectively.
The deck names the two differences that matter.
Chitin in the wall. Not peptidoglycan — so penicillin, which attacks peptidoglycan cross-linking (Unit 2 §3), does nothing. That is why the resistance list in §5 includes tetracycline, penicillin and streptomycin as agents fungi are resistant to. Human cells have no wall at all, so the fungal wall is a good target in principle.
Ergosterol instead of cholesterol in the membrane. This is the single most exploited difference in antifungal therapy. Azoles — ketoconazole, fluconazole, itraconazole — block ergosterol synthesis; amphotericin B and nystatin bind ergosterol directly and punch holes in the membrane.
And it explains the side effects: our membranes contain cholesterol, which is similar enough that amphotericin B binds it too — hence its notorious toxicity.
One letter of difference in a sterol; an entire drug class.
- How big are fungi compared with bacteria? → 10–15 µm, larger than cocci (0.8 µm), bacilli (4–6 µm) and spirochaetes (8–10 µm)
- What is the fungal cell wall made of? → Chitin, proteins, polysaccharides and lipids — multilayered and rigid, with NO peptidoglycan
- What sterol is in the membrane, and why does it matter? → Ergosterol instead of cholesterol — the target of azoles (ketoconazole, fluconazole, itraconazole)
- Which ribosome do fungi have? → 80S — a eukaryotic ribosome
- Which fungus has a capsule, and what is it? → Cryptococcus neoformans — thick, polysaccharide, and a virulence factor
⭐ The two basic morphological forms ★★★
| Yeast form | Mould form | |
|---|---|---|
| Cellularity | Unicellular | Multicellular |
| Shape | Roughly spherical | Hyphae and spores |
| Reproduction | BUDDING or fission; may form pseudohyphae / pseudomycelium | By spores |
| Colony | Moist or mucoid | Filamentous |
| Examples | Cryptococcus neoformans · Candida albicans | Penicillium and other moulds |
Branching, threadlike filaments of fungi that elongate at their tips.
| Classification of hyphae | Types |
|---|---|
| Based on structure | SEPTATE hyphae · COENOCYTIC (non-septate) hyphae |
| Based on function | VEGETATIVE hypha · AERIAL hypha · REPRODUCTIVE hypha — an aerial hypha that produces spores |
A mass of hyphae collectively making up the mycelium.
- Name the two basic morphological forms. → Yeast (unicellular, spherical, reproducing by budding or fission, moist mucoid colonies) and mould (multicellular, with hyphae and spores)
- Define a hypha. → A branching, threadlike filament of fungus that elongates at its tip
- How are hyphae classified? → By structure into septate and coenocytic (non-septate); by function into vegetative, aerial and reproductive (an aerial hypha producing spores)
- Define a mycelium. → A mass of hyphae collectively
- Give two yeast-form examples. → Cryptococcus neoformans and Candida albicans
⭐ Spores and dimorphism ★★★
The reproductive structure or unit of fungi.
| Sexual spores — by MEIOSIS, haploid | Asexual spores — by MITOSIS |
|---|---|
| Zygospores | Conidium — MACROconidia (large, multicelled) and MICROconidia (small, single-celled) |
| Ascospores | Thallospore |
| Basidiospores | Blastospore |
| Oospores | Chlamydospore · Arthrospore · Sporangiospore |
⭐ Fungal spores versus bacterial spores — a set question
| Spores of FUNGI | Spores of BACTERIA | |
|---|---|---|
| Resistance to heat | WEAK — killed at 60 °C in 1 hour | STRONG — survive 100 °C for 1–2 hours |
| Number | One hypha can produce MANY spores | One bacterial cell can form only ONE spore |
| Purpose | A REPRODUCTIVE form of fungi | NOT a reproductive form for bacteria — it is a survival form |
Medically important fungi are DIMORPHIC — they grow as a YEAST form (the parasitic, tissue, unicellular form; e.g. Candida cultured at 35–37 °C) or as a MOULD form (the saprophytic, multicellular form; e.g. Candida cultured at 25 °C). The dimorphic transition depends on oxidation-reduction potential, pH and other factors, and RELATES TO PATHOGENICITY.
Dimorphic fungi: Coccidioides immitis · Paracoccidioides brasiliensis · Blastomyces dermatitidis · Histoplasma capsulatum.
Yeast at 35–37 °C; mould at 25 °C. Those two numbers are body temperature and room temperature, and that is the entire point.
In the soil, at ambient temperature, the fungus grows as a mould — filamentous, producing airborne spores. Inhale those spores and, at 37 °C, the organism converts to the yeast form: single cells, no hyphae, small enough to live inside a macrophage.
That is why the deck says the transition relates to pathogenicity, and why §6 says the systemic mycoses overcome host physiological and cellular defences by changing their morphological form and often initiate in the lungs by inhalation of conidia.
Two practical consequences: the laboratory grows the diagnostic mould form at 25 °C while the patient's tissue shows the yeast form — so the same organism looks like two different things depending on where you look. And handling those cultures is hazardous, because a plate of mould is a plate of infectious spores.
Note also the contrast in the spore table: fungal spores are for reproduction and die at 60 °C; bacterial spores are for survival and resist 100 °C. Same word, opposite biology — which is exactly why Unit 7 said the criterion of sterilisation is killing bacterial spores.
- Define a fungal spore. → The reproductive structure or unit of fungi
- Name the sexual and asexual spores. → Sexual (meiosis): zygospores, ascospores, basidiospores, oospores. Asexual (mitosis): conidia (macro- and microconidia), thallospores, blastospores, chlamydospores, arthrospores, sporangiospores
- Give three differences between fungal and bacterial spores. → Heat resistance weak (60 °C/1 h) vs strong (100 °C/1–2 h) · one hypha makes many vs one cell makes one · reproductive vs not reproductive
- Define fungal dimorphism. → Growth as a yeast (parasitic, tissue, unicellular) form at 35–37 °C or a mould (saprophytic, multicellular) form at 25 °C, depending on redox potential and pH — and related to pathogenicity
- Name four dimorphic fungi. → Coccidioides immitis, Paracoccidioides brasiliensis, Blastomyces dermatitidis, Histoplasma capsulatum
Cultivation and resistance ★★★
| Detail | |
|---|---|
| Medium | SABOURAUD'S AGAR — 4% glucose, 1% peptone, pH 5.6 |
| Conditions | 22–28 °C, pH 4–6; high moisture and oxygen |
| Colony type | Description | Example |
|---|---|---|
| a · Yeast colony | Round, mucoid, creamy, opaque | Cryptococcus neoformans |
| b · Yeast-like colony | As above, but with pseudohyphae | Candida albicans |
| c · Filamentous colony | Hairy, fluffy and cottony | Mould — e.g. Penicillium |
| Resistant to | Sensitive to |
|---|---|
| Drying, UV, acid and alkali | Heat — killed at 60 °C for 1 hour |
| Tetracycline, penicillin, streptomycin and other ANTIBACTERIALS | Phenol (1–3%), iodine (2.5%), formalin (10%) |
| Amphotericin B, ketoconazole, fluconazole, itraconazole, griseofulvin, nystatin |
- What medium, and what conditions? → Sabouraud's agar (4% glucose, 1% peptone, pH 5.6) at 22–28 °C, pH 4–6, with high moisture and oxygen
- Name the three colony types with examples. → Yeast (round, mucoid, creamy, opaque — Cryptococcus) · yeast-like (Candida albicans) · filamentous, hairy, fluffy and cottony (moulds)
- What are fungi resistant to? → Drying, UV, acid and alkali, and antibacterials such as tetracycline, penicillin and streptomycin
- What are they sensitive to? → Heat (60 °C for 1 hour), phenol 1–3%, iodine 2.5%, formalin 10%, and the antifungals amphotericin B, the azoles, griseofulvin and nystatin
⭐ Pathogenicity and the five types of mycosis ★★★
About 400 fungal species cause human disease; 50–100 species are common. The major physiologic barriers against them are temperature, redox potential and cellular immune defences.
| Human factors | Fungal factors |
|---|---|
| Low immunity state | Invasive structures, enzymes, toxins |
| Environmental exposure | Dimorphism · ability to block host cell-mediated immune defences |
The deck's conclusion is worth quoting: “Generally, human mycosis development is related primarily to the HOST IMMUNE STATUS and ENVIRONMENTAL EXPOSURE, rather than to the infecting organism.”
| Virulence factor | Example |
|---|---|
| Capsules — antiphagocytosis | Cryptococcus neoformans, Histoplasma capsulatum |
| Enzymes — digest host cells | Keratinase (dermatophytes) |
| Mycotoxins | Poisoning; mutagenic and carcinogenic |
⭐ The five types of mycosis
| Type | Detail |
|---|---|
| A · Pathogenic fungal infection | Four levels — below |
| B · Opportunistic fungal infection | Endogenous infection — e.g. thrush |
| C · Hypersensitivity | Allergens: hypha, spores, fungal products. Diseases: urticaria, rhinitis, asthma, allergic dermatitis |
| D · Mycotoxicosis | Mycotoxins ingested by humans → poisoning |
| E · Fungal toxins causing tumours | Aspergillus flavus → AFLATOXIN → HEPATOMA |
A · Pathogenic fungal infection — by the tissue infected
| Level | Detail |
|---|---|
| I · Superficial infection | Involves only the outermost layer of skin and hair shaft — the stratum corneum and hair cuticle. NO living tissue is invaded, NO pathological changes, NO cellular response; patients are often unaware. Pityriasis versicolor (Malassezia furfur, a lipophilic yeast) · tinea nigra (Exophiala werneckii) |
| II · Cutaneous infection | Deeper in the epidermis and keratinised tissues — skin, hair, nails. NO living tissue is invaded, but a variety of pathological changes (skin lesions) occur, from irritation by fungal growth and toxic metabolic products. DERMATOPHYTOSIS — TINEA (ringworm): tinea corporis, capitis, cruris, pedis (“athlete's foot”), unguium, barbae |
| III · Subcutaneous infection | Causative fungi are SOIL SAPROPHYTES; they involve the dermis, subcutaneous tissue and muscle, INVADE THROUGH TRAUMA, and cause CHRONIC GRANULOMATOUS disease. Chromoblastomycosis, sporotrichosis, mycetoma, lobomycosis, subcutaneous zygomycosis |
| IV · Dimorphic systemic mycoses | Dimorphic fungal pathogens OVERCOME host physiological and cellular defences BY CHANGING THEIR MORPHOLOGICAL FORM. Specifically organophilic; GEOGRAPHICALLY RESTRICTED; often initiate in the lungs by INHALATION OF CONIDIA; involve deep viscera. Blastomycosis — south-eastern and south-central North America · Coccidioidomycosis — south-western USA, Mexico, Central and parts of South America · Paracoccidioidomycosis — South and Central America · Histoplasmosis — endemic in certain areas of the USA |
B · The opportunistic fungi
| Disease | Organism | Detail |
|---|---|---|
| Candidiasis | Candida albicans | Exists in the human mouth, gut, vagina and skin surface. Mucocutaneous infection — thrush, vaginitis · organ infection — bronchitis, pneumonia, oesophagitis, enteritis, endocarditis, septicaemia · CNS infection — meningitis · allergic disease |
| Cryptococcosis | Cryptococcus neoformans | Round, CAPSULATE, 3–5 µm; grows on blood agar and Sabouraud's agar as a yeast-form colony. Saprophytic, widely present in SOIL and PIGEON FAECES; an opportunistic EXOGENOUS infection. Main portal of entry: the LUNG. Most cases asymptomatic; a few develop pneumonia; and CRYPTOCOCCAL MENINGITIS |
| Aspergillosis | Aspergillus | Pulmonary aspergillosis · mycotoxicosis and cancer |
| Mucormycosis | Mucor | |
| PCP | Pneumocystis carinii | Pneumocystis carinii pneumonia — a MAJOR CAUSE OF DEATH among AIDS patients |
That sentence from the deck is the most important line in the unit, and it separates mycology from every module before it.
With Staphylococcus aureus or Vibrio cholerae, the organism brings toxins and invasins and can make a healthy person ill. Most fungi cannot. They are everywhere — in soil, in the air, on our skin, in our gut — and they are held off by intact skin, by body temperature, and above all by cell-mediated immunity.
So the fungal diseases that matter clinically are, overwhelmingly, diseases of the immunocompromised:
• Thrush and oesophageal candidiasis — after antibiotics (Unit 5 §3's loss of antagonism) or in AIDS
• Cryptococcal meningitis — the classic AIDS opportunist, from soil and pigeon droppings
• PCP — a major cause of death among AIDS patients, in the deck's own words
• Invasive aspergillosis and mucormycosis — neutropenia, transplantation, poorly controlled diabetes
Which closes the circle with Unit 26 §6: the AIDS-defining illnesses are the infections controlled by CD4 cells, and half of them are fungal.
- What determines whether a mycosis develops? → Primarily the host immune status and environmental exposure, rather than the infecting organism
- Name the three fungal virulence factors with examples. → Capsules for antiphagocytosis (Cryptococcus, Histoplasma) · enzymes digesting host cells (keratinase of dermatophytes) · mycotoxins causing poisoning and being mutagenic and carcinogenic
- Name the five types of mycosis. → Pathogenic fungal infection · opportunistic fungal infection · hypersensitivity · mycotoxicosis · fungal toxins causing tumours
- Name the four levels of pathogenic fungal infection. → Superficial, cutaneous, subcutaneous, dimorphic systemic
- Superficial vs cutaneous infection? → Both invade no living tissue, but superficial causes no pathological change or cellular response (patients often unaware), while cutaneous causes skin lesions from irritation and toxic metabolites
- Which fungus causes meningitis, and where does it come from? → Cryptococcus neoformans, from soil and pigeon faeces, entering via the lung
- Which fungus causes hepatoma, and by what toxin? → Aspergillus flavus, via aflatoxin
- Name the opportunistic fungi. → Candida albicans, Cryptococcus neoformans, Aspergillus, Mucor, Pneumocystis carinii
⭐ The deck's own definitions and questions
Hypha — a branching, threadlike filament of fungus that elongates at its tip.
Mycelium — a mass of hyphae collectively.
Fungal spore — the reproductive structure or unit of fungi, sexual (by meiosis) or asexual (by mitosis).
Fungal dimorphism — growth as the yeast (parasitic, tissue, unicellular) form at 35–37 °C or the mould (saprophytic, multicellular) form at 25 °C, depending on redox potential and pH, and related to pathogenicity.
Harmful — about 400 species cause human disease, as pathogens and opportunistic pathogens: mycoses (superficial, cutaneous, subcutaneous, systemic and allergic), fungal toxins causing poisoning, and cancer.
Candida albicans — normal flora of mouth, gut, vagina and skin: mucocutaneous infection (thrush, vaginitis) · organ infection (bronchitis, pneumonia, oesophagitis, enteritis, endocarditis, septicaemia) · CNS infection (meningitis) · allergic disease.
The opportunistic fungi: Candida albicans · Cryptococcus neoformans · Aspergillus · Mucor · Pneumocystis carinii (PCP — a major cause of death among AIDS patients).
Revision
The whole unit on one screen
| Question | Answer |
|---|---|
| Fungi? | Eukaryotic, spore-bearing, non-photosynthetic microbes without chlorophyll |
| Size? | 10–15 µm — larger than any bacterium |
| Wall? | Chitin — no peptidoglycan, so penicillin fails |
| Membrane? | Ergosterol — the azole and amphotericin B target |
| Two forms? | Yeast (unicellular, budding) and mould (hyphae and spores) |
| Hypha / mycelium? | Branching threadlike filament elongating at its tip / a mass of hyphae |
| Dimorphism? | Yeast at 35–37 °C, mould at 25 °C; related to pathogenicity |
| Fungal vs bacterial spores? | Weak vs strong heat resistance · many vs one · reproductive vs not |
| Medium? | Sabouraud's agar, 22–28 °C, pH 4–6 |
| 5 mycoses? | Pathogenic · opportunistic · hypersensitivity · mycotoxicosis · tumour |
| 4 pathogenic levels? | Superficial · cutaneous (tinea) · subcutaneous · dimorphic systemic |
| Opportunists? | Candida · Cryptococcus · Aspergillus · Mucor · PCP |
| Aflatoxin? | From Aspergillus flavus → hepatoma |
- Define fungi, hypha, mycelium, fungal spore and dimorphism. → See §7
- Name the five types of mycosis. → Pathogenic fungal infection, opportunistic fungal infection, hypersensitivity, mycotoxicosis, fungal toxins causing tumours
- Give the differences between bacteria and fungi. → Prokaryote vs eukaryote · smaller vs 10–15 µm · peptidoglycan vs chitin · no sterol vs ergosterol · 70S vs 80S ribosome · nucleoid vs true nucleus · binary fission vs budding and spores · antibacterial-sensitive vs antifungal-sensitive
- Give the differences between bacterial and fungal spores. → Fungal spores are heat-labile (60 °C/1 h), many per hypha, and reproductive; bacterial spores are heat-resistant (100 °C/1–2 h), one per cell, and not reproductive
- Why are most fungal diseases diseases of the immunocompromised? → Mycosis development depends primarily on host immune status and environmental exposure rather than on the organism — the main barriers are temperature, redox potential and cell-mediated immunity